Bing

SEARCH HISTORY

Leerink analysts Jason Schwartz and Mayank Mamtani have raised their price target on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock from $559 per share to $630, a 13.70% upside on the stock's last …
bidnessetc.com · 18 hours ago
Regeneron Pharmaceuticals Inc
Healthcare stocks rose 0.4% on Wall Street on Tuesday morning. More broadly, the Dow Jones Industrial Average stayed level, the Nasdaq was steady and the S&P 500 was unchanged. Some of the biggest gainers among healthcare stocks include: IPC …
Investor Place · 16 hours ago
REGN, along with Gilead Sciences (NASDAQ:GILD), is one of the only two large-cap biotechs that I have both written about the most and about which I have only commented positively, both about the company and the …
Seeking Alpha · 8 hours ago
REGN
More from Bing News
[PR Newswire] – TARRYTOWN, N.Y., Aug. 4, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced financial results for the second quarter of 2015 and provided an update on …
Jutia Group · 17 hours ago
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (NASDAQ:REGN)‘s stock had its “outperform” rating restated by analysts at Sanford C. Bernstein in a report issued on Tuesday, Market Beat.com reports. Regeneron Pharmaceuticals (NASDAQ:REGN) traded up 4.81% …
Ticker Report · 6 hours ago
Regeneron Pharmaceuticals
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Regeneron Pharmaceuticals ( REGN) as a momo ...
The Street · 7/28/2015
Regeneron Pharmaceuticals
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >> Get the latest research report on REGN - FREE
ZACKS · 22 hours ago
Regeneron
In-depth coverage >
(RTTNews.com) - Regeneron Pharmaceuticals Inc. ( REGN) reported second quarter non-GAAP EPS of $ ... gapped open sharply higher this morning and is now up 33.25 at $587.52. The stock has broken out of a 2 1/2 week trading range and has set a …
NASDAQ · 19 hours ago
Regeneron Pharmaceuticals
"I think as this relates to the Federal Reserve, the Federal Reserve is quite comfortable with improvement we've been having in labor," he said, noting that the stock market will likely have a reaction. In corporate news, Regeneron Pharmaceuticals (REGN ...
Yahoo Finance · 18 hours ago
stocks
... funds the past three months have continued to gobble up top-rated medical stocks, such as Allergan (NYSE:AGN), Celgene (NASDAQ:CELG), Regeneron Pharmaceuticals (NASDAQ:REGN), Molina Healthcare (NYSE:MOH) and Acadia Healthcare …
Investors Business Daily · 10 hours ago
Mutual Funds

Regeneron

Company
Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in …
Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, it branched out into the study of both cytokine and tyrosine kinase receptors.
Data from: Wikipedia · Freebase